103 related articles for article (PubMed ID: 10951627)
1. [Expression of CPP32, Fas and Fas ligand and the relationship between their expression and viral antigens in chronic hepatitis].
Zhao J; Wang S; Xin S; Yi T; Liu P; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):233-5. PubMed ID: 10951627
[TBL] [Abstract][Full Text] [Related]
2. [Study on expression of Fas/FasL and HBV antigens in liver tissue of patients with hepatitis B].
Wang H; Hu J; Zhu K
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):12-5. PubMed ID: 12526294
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum soluble Fas, Fas ligand and fas in intrahepatic lymphocytes in chronic hepatitis C.
Zaki Mel S; Auf FA; Ghawalby NA; Saddal NM
Immunol Invest; 2008; 37(2):163-70. PubMed ID: 18300041
[TBL] [Abstract][Full Text] [Related]
4. Fas and its ligand, caspases, and bcl-2 expression in gonadotropin-releasing hormone agonist-treated uterine leiomyoma.
Huang SC; Tang MJ; Hsu KF; Cheng YM; Chou CY
J Clin Endocrinol Metab; 2002 Oct; 87(10):4580-6. PubMed ID: 12364438
[TBL] [Abstract][Full Text] [Related]
5. [The role of Fas/FasL system in induction of hepatocyte apoptosis in chronic viral hepatitides].
Dmitrieva EV; Moskaleva EIu; Kogan EA; Bueverov AO; Belushkina NN; Ivashkin VT; Severin ES; Pal'tsev MA
Arkh Patol; 2003; 65(6):13-7. PubMed ID: 14964961
[TBL] [Abstract][Full Text] [Related]
6. Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection.
Macias J; Japón MA; Sáez C; Palacios RB; Mira JA; García-García JA; Merchante N; Vergara S; Lozano F; Gómez-Mateos J; Pineda JA
J Infect Dis; 2005 Nov; 192(9):1566-76. PubMed ID: 16206071
[TBL] [Abstract][Full Text] [Related]
7. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
Bortolami M; Kotsafti A; Cardin R; Farinati F
J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
[TBL] [Abstract][Full Text] [Related]
8. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure.
Mita A; Hashikura Y; Tagawa Y; Nakayama J; Kawakubo M; Miyagawa S
Am J Gastroenterol; 2005 Nov; 100(11):2551-9. PubMed ID: 16279913
[TBL] [Abstract][Full Text] [Related]
9. Expression of perforin and Fas ligand mRNA in the liver of viral hepatitis.
Tagashira M; Yamamoto K; Fujio K; Nagano T; Okamoto R; Ibuki N; Yabushita K; Matsumura S; Okano N; Tsuji T
J Clin Immunol; 2000 Sep; 20(5):347-53. PubMed ID: 11051276
[TBL] [Abstract][Full Text] [Related]
10. In situ expression of Granzyme B and Fas-ligand in the liver of viral hepatitis.
Ibuki N; Yamamoto K; Yabushita K; Okano N; Okamoto R; Shimada N; Hakoda T; Mizuno M; Higashi T; Tsuji T
Liver; 2002 Jun; 22(3):198-204. PubMed ID: 12100569
[TBL] [Abstract][Full Text] [Related]
11. Induction of Fas-mediated apoptosis in a human renal epithelial cell line by interferon-gamma: involvement of Fas-mediated apoptosis in acute renal rejection.
Akasaka Y; Ishikawa Y; Kato S; Ishii T; Masuda T; Fujita K; Yamada T; Kawamura S
Mod Pathol; 1998 Nov; 11(11):1107-14. PubMed ID: 9831209
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
13. [The localization of FasL mRNA in liver tissues of chronic hepatitis B].
Hu J; Zhang L; Zhao J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec; 12(4):316-7. PubMed ID: 12526342
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase.
Wei SJ; Chao Y; Shih YL; Yang DM; Hung YM; Yang WK
Gene Ther; 1999 Mar; 6(3):420-31. PubMed ID: 10435092
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
16. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?
Nagao M; Nakajima Y; Hisanaga M; Kayagaki N; Kanehiro H; Aomatsu Y; Ko S; Yagita H; Yamada T; Okumura K; Nakano H
Hepatology; 1999 Aug; 30(2):413-21. PubMed ID: 10421649
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
18. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
19. In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas.
Lee SH; Shin MS; Lee JY; Park WS; Kim SY; Jang JJ; Dong SM; Na EY; Kim CS; Kim SH; Yoo NJ
J Pathol; 1999 Jun; 188(2):207-12. PubMed ID: 10398166
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
